These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 36435792)

  • 1. Optimal control strategies of SARS-CoV-2 Omicron supported by invasive and dynamic models.
    Rui J; Zheng JX; Chen J; Wei H; Yu S; Zhao Z; Wang XY; Chen MX; Xia S; Zhou Y; Chen T; Zhou XN
    Infect Dis Poverty; 2022 Nov; 11(1):115. PubMed ID: 36435792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiological characteristics and transmission dynamics of the outbreak caused by the SARS-CoV-2 Omicron variant in Shanghai, China: a descriptive study.
    Chen Z; Deng X; Fang L; Sun K; Wu Y; Che T; Zou J; Cai J; Liu H; Wang Y; Wang T; Tian Y; Zheng N; Yan X; Sun R; Xu X; Zhou X; Ge S; Liang Y; Yi L; Yang J; Zhang J; Ajelli M; Yu H
    medRxiv; 2022 Jun; ():. PubMed ID: 35765564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological characteristics and transmission dynamics of the outbreak caused by the SARS-CoV-2 Omicron variant in Shanghai, China: A descriptive study.
    Chen Z; Deng X; Fang L; Sun K; Wu Y; Che T; Zou J; Cai J; Liu H; Wang Y; Wang T; Tian Y; Zheng N; Yan X; Sun R; Xu X; Zhou X; Ge S; Liang Y; Yi L; Yang J; Zhang J; Ajelli M; Yu H
    Lancet Reg Health West Pac; 2022 Dec; 29():100592. PubMed ID: 36090701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The rapid and efficient strategy for SARS-CoV-2 Omicron transmission control: analysis of outbreaks at the city level.
    Zheng JX; Lv S; Tian LG; Guo ZY; Zheng PY; Chen YL; Guan SY; Wang WM; Zhang SX
    Infect Dis Poverty; 2022 Nov; 11(1):114. PubMed ID: 36434701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overlapping Delta and Omicron Outbreaks During the COVID-19 Pandemic: Dynamic Panel Data Estimates.
    Lundberg AL; Lorenzo-Redondo R; Hultquist JF; Hawkins CA; Ozer EA; Welch SB; Prasad PVV; Achenbach CJ; White JI; Oehmke JF; Murphy RL; Havey RJ; Post LA
    JMIR Public Health Surveill; 2022 Jun; 8(6):e37377. PubMed ID: 35500140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic zero-COVID strategy in controlling COVID-19 in Shanghai, China: A cost-effectiveness analysis.
    Tan C; Luo X; Zhou Z; Zeng X; Wan X; Yi L; Liu Q
    J Infect Public Health; 2023 Jun; 16(6):893-900. PubMed ID: 37062164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model-based analysis of the incidence trends and transmission dynamics of COVID-19 associated with the Omicron variant in representative cities in China.
    Ma Y; Xu S; Luo Y; Li J; Lei L; He L; Wang T; Yu H; Xie J
    BMC Public Health; 2023 Dec; 23(1):2400. PubMed ID: 38042794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiological characteristics and dynamic transmissions of COVID-19 pandemics in Chinese mainland: A trajectory clustering perspective analysis.
    Chen J; Chen S; Duan G; Zhang T; Zhao H; Wu Z; Yang H; Ding S
    Epidemics; 2023 Dec; 45():100719. PubMed ID: 37783112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmission Characteristics and Predictive Model for Recent Epidemic Waves of COVID-19 Associated With OMICRON Variant in Major Cities in China.
    Zheng Y; Wang Y
    Int J Public Health; 2022; 67():1605177. PubMed ID: 36405530
    [No Abstract]   [Full Text] [Related]  

  • 10. Optimal timing and effectiveness of COVID-19 outbreak responses in China: a modelling study.
    Zhang AZ; Enns EA
    BMC Public Health; 2022 Apr; 22(1):679. PubMed ID: 35392861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of COVID-19 vaccines against SARS-CoV-2 Omicron variants during two outbreaks from March to May 2022 in Quzhou, China.
    Yin Z; Fang Q; Wen T; Zheng C; Fu C; Wang S; Li J; Gong X
    Hum Vaccin Immunother; 2023 Dec; 19(1):2163813. PubMed ID: 36704960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-specific transmission dynamics under suppression control measures during SARS-CoV-2 Omicron BA.2 epidemic.
    Zhu W; Wen Z; Chen Y; Gong X; Zheng B; Liang X; Xu A; Yao Y; Wang W
    BMC Public Health; 2023 Apr; 23(1):743. PubMed ID: 37087436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico evaluation of the impact of Omicron variant of concern sublineage BA.4 and BA.5 on the sensitivity of RT-qPCR assays for SARS-CoV-2 detection using whole genome sequencing.
    Sharma D; Notarte KI; Fernandez RA; Lippi G; Gromiha MM; Henry BM
    J Med Virol; 2023 Jan; 95(1):e28241. PubMed ID: 36263448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmission Characteristics and Inactivated Vaccine Effectiveness Against Transmission of SARS-CoV-2 Omicron BA.5 Variants in Urumqi, China.
    Wang K; Guo Z; Zeng T; Sun S; Lu Y; Wang J; Li S; Luan Z; Li H; Zhang J; Wang Y; Lu Y; Zhao S
    JAMA Netw Open; 2023 Mar; 6(3):e235755. PubMed ID: 36995713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons drawn from Shanghai for controlling highly transmissible SARS-CoV-2 variants: insights from a modelling study.
    Wang H; Li T; Gao H; Huang C; Tang B; Tang S; Cheke RA; Zhou W
    BMC Infect Dis; 2023 May; 23(1):331. PubMed ID: 37194011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parametric analysis of the transmission dynamics during indigenous aggregated outbreaks caused by five SARS-CoV-2 strains in Nanjing, China.
    Ma T; Chen C; Wang J; Wang H; Zhao Y; Zhu Y; Yan Z; Ding S; Ding J
    Front Public Health; 2024; 12():1358577. PubMed ID: 38525336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of prevention and control measures toward COVID-19 epidemic between Shanghai and Beijing.
    Meng Y; Wang X; Dong P; Yang Y; Wang K; Yan X; Hu G; Mao A; Qiu W
    Front Public Health; 2023; 11():1121846. PubMed ID: 37139394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Policy choices for Shanghai responding to challenges of Omicron.
    Qian Y; Cao S; Zhao L; Yan Y; Huang J
    Front Public Health; 2022; 10():927387. PubMed ID: 36016887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of epidemiological characteristics and transmissibility of different strains of COVID-19 based on the incidence data of all local outbreaks in China as of March 1, 2022.
    Niu Y; Luo L; Yang S; Abudurusuli G; Wang X; Zhao Z; Rui J; Li Z; Deng B; Liu W; Zhang Z; Li K; Liu C; Li P; Huang J; Yang T; Wang Y; Chen T; Li Q
    Front Public Health; 2022; 10():949594. PubMed ID: 36187650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of the emergency response strategies and measures on the epidemic of COVID-19 in Shenzhen, China].
    Zou X; Wu YS; Liu XJ; Huang SL; He JF; Zhao J; Wu N; Zhang RL; Mei SJ; Liu PY; Zhang Z; Shi XL; Lyu X; Wei L; Ma QS; Lu JH; Li Y; Feng TJ; Peng CQ; Zhang SX; Xia JJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Aug; 41(8):1225-1230. PubMed ID: 32340094
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.